Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Central carbon metabolism in cancer	5/70	1.0300956143193924e-08	1.236114737183271e-06	123.12307692307692	-308.3116784019305	AKT1;MTOR;PIK3CA;PTEN;RET
KEGG_2021_Human	Autophagy	5/137	3.070399768694536e-07	1.8422398612167214e-05	60.121212121212125	-177.50304940933535	AKT1;AMBRA1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Glioma	4/75	1.3800270600312918e-06	5.520108240125167e-05	75.08920187793427	-173.9277482736146	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	8.247325689181237e-05	62.61176470588235	-150.9687540546772	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Prostate cancer	4/97	3.882535399026648e-06	9.318084957663956e-05	57.168458781362006	-140.4227070470985	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Insulin resistance	4/108	5.9656924897832925e-06	0.00011931384979566584	51.05128205128205	-128.12895940589095	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Spinocerebellar ataxia	4/143	1.820556871612203e-05	0.00030456511790290496	38.02877697841727	-100.11084528203472	AKT1;AMBRA1;MTOR;PIK3CA
KEGG_2021_Human	Breast cancer	4/147	2.0304341193526998e-05	0.00030456511790290496	36.946386946386944	-97.65028859286629	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Cellular senescence	4/156	2.5674697719867903e-05	0.00030809637263841486	34.719298245614034	-92.51470316480022	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	mTOR signaling pathway	4/154	2.4400135505395987e-05	0.00030809637263841486	35.19111111111111	-93.61108375071908	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Hepatocellular carcinoma	4/168	3.4380880466544094e-05	0.0003750641505441174	32.13008130081301	-86.4138745753221	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Endometrial cancer	3/58	4.0678393529377954e-05	0.0004067839352937795	62.43896103896104	-110.94009813873689	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Acute myeloid leukemia	3/67	6.278481738010982e-05	0.0005795521604317829	53.598214285714285	-98.46843432757142	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Diabetic cardiomyopathy	4/203	7.221114673256542e-05	0.0005843260753993818	26.36180904522613	-72.26295411298177	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Melanoma	3/72	7.791014338658423e-05	0.0005843260753993818	49.683229813664596	-92.7008152698569	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Non-small cell lung cancer	3/72	7.791014338658423e-05	0.0005843260753993818	49.683229813664596	-92.7008152698569	AKT1;PIK3CA;RET
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.0006465614399659719	46.93737769080235	-88.55605413655218	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.0008366784296720532	41.230636833046475	-79.65388581050792	AKT1;MTOR;PIK3CA
KEGG_2021_Human	ErbB signaling pathway	3/85	0.00012793645194335274	0.0008366784296720532	41.73867595818815	-80.46318508481777	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Small cell lung cancer	3/92	0.00016192103282048912	0.0009715261969229348	38.42215088282504	-75.11644417571499	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Choline metabolism in cancer	3/98	0.0001953427473376157	0.0011162442705006611	35.96842105263158	-71.05939608138371	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Longevity regulating pathway	3/102	0.00021994493140062025	0.0011996996258215652	34.497835497835496	-68.58379435140506	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Pathways in cancer	5/531	0.00023006625856898829	0.001200345696881678	14.338403041825096	-46.44758767649085	AKT1;MTOR;PIK3CA;PTEN;RET
KEGG_2021_Human	HIF-1 signaling pathway	3/109	0.00026769368967035696	0.0013384684483517847	32.19137466307278	-64.6303441766756	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Growth hormone synthesis, secretion and action	3/119	0.0003468783323520502	0.00153864318016812	29.379310344827587	-59.68521503911596	AKT1;MTOR;PIK3CA
KEGG_2021_Human	MicroRNAs in cancer	4/310	0.00037183876854062896	0.00153864318016812	16.910675381263616	-47.03626387241228	DICER1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.00153864318016812	29.379310344827587	-59.68521503911596	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.00153864318016812	28.87409200968523	-58.78131250266827	AKT1;MTOR;PIK3CA
KEGG_2021_Human	AMPK signaling pathway	3/120	0.0003555398588827732	0.00153864318016812	29.124542124542124	-59.230009444204136	AKT1;MTOR;PIK3CA
KEGG_2021_Human	FoxO signaling pathway	3/131	0.0004602084037564585	0.001840833615025834	26.584821428571427	-54.62268457986884	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0018493418649602076	15.781855249745158	-43.81753827074924	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Insulin signaling pathway	3/137	0.0005248515914701949	0.0019681934680132306	25.375266524520256	-52.38188378130509	AKT1;MTOR;PIK3CA
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.002243787183975517	14.700952380952382	-40.688114366493096	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.0023009453488264634	23.25440313111546	-48.37496566440217	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Phospholipase D signaling pathway	3/148	0.0006580280370873506	0.0023009453488264634	23.417733990147784	-48.687210890592894	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Alzheimer disease	4/369	0.0007223109472324288	0.0024077031574414294	14.069406392694065	-38.837531411044004	AKT1;AMBRA1;MTOR;PIK3CA
KEGG_2021_Human	JAK-STAT signaling pathway	3/162	0.000856615716023289	0.002778213133048505	21.318059299191376	-44.62403509135876	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.004231416011345278	18.161290322580644	-38.30003183551744	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.004236413873554379	17.769924812030077	-37.496518500419114	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Carbohydrate digestion and absorption	2/47	0.001447441406797746	0.004236413873554379	44.57222222222222	-52.81565568615274	AKT1;PIK3CA
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.004236413873554379	45.59090909090909	-53.767249912981214	MTOR;PIK3CA
KEGG_2021_Human	Focal adhesion	3/201	0.0016005928499043844	0.004573122428298241	17.034632034632036	-35.97452728368245	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Proteoglycans in cancer	3/205	0.0016941022902244062	0.004727727321556482	16.68882602545969	-35.25303962280841	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.005088928411830809	16.115516062884485	-34.04865723073064	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Regulation of lipolysis in adipocytes	2/55	0.0019779052882580696	0.005274414102021519	37.806603773584904	-46.277866103498205	AKT1;PIK3CA
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.005343720917959629	15.579365079365079	-32.91284230349772	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.005651500783486442	15.146718146718147	-31.989452913184095	AKT1;MTOR;PIK3CA
KEGG_2021_Human	VEGF signaling pathway	2/59	0.0022729027659621377	0.005682256914905344	35.1359649122807	-43.58275967856779	AKT1;PIK3CA
KEGG_2021_Human	Ras signaling pathway	3/232	0.0024164136009215383	0.0059177475940935635	14.670617592014972	-30.966105875434415	AKT1;NF1;PIK3CA
KEGG_2021_Human	Chemical carcinogenesis	3/239	0.0026306580335614905	0.006280542402457081	14.2227602905569	-29.996427445990946	AKT1;MTOR;PIK3CA
KEGG_2021_Human	GnRH secretion	2/64	0.0026692305210442593	0.006280542402457081	32.28225806451613	-40.62246695267589	AKT1;PIK3CA
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.0065918465867200364	13.800705467372135	-29.076248648200146	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Adipocytokine signaling pathway	2/69	0.0030959091544989293	0.006754710882543119	29.854477611940297	-38.032897794694755	AKT1;MTOR
KEGG_2021_Human	Renal cell carcinoma	2/69	0.0030959091544989293	0.006754710882543119	29.854477611940297	-38.032897794694755	AKT1;PIK3CA
KEGG_2021_Human	Fc epsilon RI signaling pathway	2/68	0.0030081604419031007	0.006754710882543119	30.310606060606062	-38.524679686703344	AKT1;PIK3CA
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.006824698607700939	29.41176470588235	-37.553176952571945	AKT1;PIK3CA
KEGG_2021_Human	Inositol phosphate metabolism	2/73	0.0034588938624005605	0.007281881815580127	28.158450704225352	-36.181927711809635	PIK3CA;PTEN
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.007745486804305938	27.006756756756758	-34.90410589940028	AKT1;PIK3CA
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.00862758717393161	25.281645569620252	-32.95657984925952	AKT1;PIK3CA
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	2/97	0.006031622120792857	0.011865486139264638	20.981578947368423	-27.909669646620806	AKT1;PIK3CA
KEGG_2021_Human	Phosphatidylinositol signaling system	2/97	0.006031622120792857	0.011865486139264638	20.981578947368423	-27.909669646620806	PIK3CA;PTEN
KEGG_2021_Human	Progesterone-mediated oocyte maturation	2/100	0.006399778215208473	0.012190053743254234	20.331632653061224	-27.120602948412195	AKT1;PIK3CA
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.012190053743254234	20.331632653061224	-27.120602948412195	AKT1;PIK3CA
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.012369670617611246	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.012369670617611246	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.012369670617611246	19.92	-26.61700675496218	AKT1;PIK3CA
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.012369670617611246	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.014070099274785202	18.086363636363636	-24.33571316400054	AKT1;PIK3CA
KEGG_2021_Human	Cholinergic synapse	2/113	0.008111349626545349	0.014106695002687564	17.92117117117117	-24.127023560492017	AKT1;PIK3CA
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.015366882067894602	16.98931623931624	-22.939511285821055	AKT1;PIK3CA
KEGG_2021_Human	Platelet activation	2/124	0.009704304916610982	0.01640164211258194	16.2827868852459	-22.027132854342252	AKT1;PIK3CA
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.016935540530054277	15.886	-21.510038502238015	AKT1;PIK3CA
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.017213124491744742	15.631889763779528	-21.1770620526928	AKT1;PIK3CA
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.01855799648955271	14.690740740740742	-19.931093924152265	AKT1;PIK3CA
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.01855799648955271	14.690740740740742	-19.931093924152265	AKT1;PIK3CA
KEGG_2021_Human	Apelin signaling pathway	2/137	0.011753397776716717	0.01855799648955271	14.690740740740742	-19.931093924152265	AKT1;MTOR
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.018591312451803524	14.472627737226277	-19.639406588988233	AKT1;PIK3CA
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.018591312451803524	14.472627737226277	-19.639406588988233	AKT1;PIK3CA
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.019121830306331706	14.157142857142857	-19.21549786230027	AKT1;PIK3CA
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	2/143	0.01275865818396982	0.01913798727595473	14.054964539007091	-19.077689748676264	AKT1;PIK3CA
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.022043594153782306	12.933006535947712	-17.54750234216727	AKT1;PIK3CA
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.02231263726597535	12.762903225806452	-17.312716751580805	AKT1;PIK3CA
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.023397369210738702	12.35625	-16.748364182562245	AKT1;PIK3CA
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.025898632505197274	11.614705882352942	-15.707848772731996	AKT1;PIK3CA
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.02848214194242215	6.556709956709956	-12.239051897711217	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Chemokine signaling pathway	2/192	0.0223068963273402	0.031125901852102605	10.365789473684211	-13.920708621090329	AKT1;PIK3CA
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.03384082147930005	9.835	-13.147442958027579	AKT1;PIK3CA
KEGG_2021_Human	Rap1 signaling pathway	2/210	0.026381440852868025	0.035974692072092765	9.447115384615385	-12.577019344618241	AKT1;PIK3CA
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.0370714797835967	9.219483568075118	-12.240131856521	AKT1;PIK3CA
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.0370714797835967	9.175233644859814	-12.174459052502558	AKT1;PIK3CA
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.04769990129545968	7.915991902834008	-10.280113155611538	AKT1;PIK3CA
KEGG_2021_Human	Thyroid cancer	1/37	0.04489527895199197	0.057929392196118666	24.790123456790123	-13.876145105511855	RET
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.057929392196118666	24.790123456790123	-13.876145105511855	PIK3CA
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.06252636947994554	6.657534246575342	-8.337786615237395	AKT1;NF1
KEGG_2021_Human	Huntington disease	2/306	0.05264626136655815	0.06650054067354715	6.384868421052632	-7.910702811009382	AMBRA1;MTOR
KEGG_2021_Human	Amyotrophic lateral sclerosis	2/364	0.07172754804182349	0.08965943505227936	5.321823204419889	-6.226988268408014	AMBRA1;MTOR
KEGG_2021_Human	Mitophagy	1/68	0.0811045146521906	0.10033548204394713	13.26865671641791	-7.96724592924887	AMBRA1
KEGG_2021_Human	p53 signaling pathway	1/73	0.0868275630671275	0.10631946498015611	12.339506172839506	-7.43259286356604	PTEN
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.11076713001982753	11.68421052631579	-7.04872976578505	PIK3CA
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.1272561338207541	9.961298377028713	-6.010407578745034	TTN
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.1336093129703204	4.014270613107822	-4.131104230952899	AMBRA1;MTOR
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.1336093129703204	9.32514619883041	-5.615549699272252	TTN
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.13393922428604849	9.130584192439862	-5.49346810373269	PIK3CA
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.137761463218633	8.764576457645765	-5.262086311101535	PIK3CA
KEGG_2021_Human	Glucagon signaling pathway	1/107	0.1249011740201087	0.14139755549446267	8.345911949685535	-4.994589105830365	AKT1
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.14139755549446267	8.345911949685535	-4.994589105830365	MTOR
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.14621837985830846	7.964964964964965	-4.748494648054986	AKT1
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.14728906209200585	7.822025565388397	-4.655477238055189	PIK3CA
KEGG_2021_Human	Dopaminergic synapse	1/132	0.1519784338028618	0.16579465505766744	6.73197625106022	-3.9335418472006	AKT1
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.16579465505766744	6.7846153846153845	-3.968927686510734	PIK3CA
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	1/150	0.1710046090025842	0.1848698475703613	5.905294556301268	-3.370661515310376	AKT1
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.20209296435844146	5.289156626506024	-2.942334294710352	AKT1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.21436743639152533	4.896958410924891	-2.6658400097237527	AKT1
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.21461329481690306	4.841620626151013	-2.6265948500338347	PIK3CA
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.23459075419923225	4.326732673267327	-2.2588473265567357	PIK3CA
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.2477213036453665	4.019969278033794	-2.037730229066884	PIK3CA
KEGG_2021_Human	Thermogenesis	1/232	0.25290994493508406	0.25719655417127196	3.7696007696007694	-1.8563524399324505	MTOR
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.25719655417127196	3.7696007696007694	-1.8563524399324505	PIK3CA
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.2626860088158704	3.6397024639702464	-1.7619943041292825	RET
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.2910658516731848	3.184640522875817	-1.4307154955453085	PIK3CA
